Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 2/2016

01-02-2016 | Original Article – Cancer Research

Prevalence of depression, anxiety and their risk factors in German women with breast cancer in general and gynecological practices

Authors: Louis Jacob, Laura Bleicher, Karel Kostev, Matthias Kalder

Published in: Journal of Cancer Research and Clinical Oncology | Issue 2/2016

Login to get access

Abstract

Aims

To analyze the prevalence of depression, anxiety and their risk factors in German women with breast cancer (BC) in general and gynecological practices (GP, GYP).

Methods

Women initially diagnosed with BC between 2009 and 2013 were identified by 1202 general practitioners and 244 gynecologists in the IMS Disease Analyzer database. They were included only if they had not suffered from depression or an anxiety disorder within the 12 months prior to the index date. The main outcome was the first diagnosis of depression or an anxiety disorder within 5 years after index date. A multivariate Cox regression model was used to predict these diagnoses on the basis of patient characteristics.

Results

A total of 24,537 patients in GP were available for the study, as well as 20,018 patients in GYP. The mean age was 65.8 and 62.5 years in GP and GYP, respectively (p value <0.0001). The proportions of depressive or anxiety episodes in the past and the proportion of metastases were higher in GP than in GYP (7.9 vs. 3.6 %, and 10.1 vs. 8.6 %, p values <0.0001). Within 5 years of follow-up, 36.9 % of GP patients and 35.1 % of GYP patients had been diagnosed with depression or anxiety. There was a significantly higher risk of depression and/or anxiety in women in the age groups 51–60, 61–70 and >70 years than in women = <50 years (OR between 1.05 and 1.27, all p values lower than 0.0359). Patients with metastases or with previous episodes of depression/anxiety had a higher risk of depression/anxiety (OR = 1.21 and 1.97, p values <0.0001). Finally, women with private health insurance had a lower risk of depression and anxiety (OR = 0.45, p value <0.0001).

Conclusion

The present study indicates that levels of depression and anxiety increase in German women after diagnosis of BC and may be predicted on the basis of several demographic and clinical characteristics.
Literature
go back to reference Baucom DH, Porter LS, Kirby JS, Gremore TM, Keefe FJ (2005) Psychosocial issues confronting young women with breast cancer. Breast Dis 23:103–113PubMed Baucom DH, Porter LS, Kirby JS, Gremore TM, Keefe FJ (2005) Psychosocial issues confronting young women with breast cancer. Breast Dis 23:103–113PubMed
go back to reference Becher H, Kostev K, Schröder-Bernhardi D (2009) Validity and representativeness of the “disease analyzer” patient database for use in pharmacoepidemiological and pharmacoeconomic studies. Int J Clin Pharmacol Ther 47:617–626PubMedCrossRef Becher H, Kostev K, Schröder-Bernhardi D (2009) Validity and representativeness of the “disease analyzer” patient database for use in pharmacoepidemiological and pharmacoeconomic studies. Int J Clin Pharmacol Ther 47:617–626PubMedCrossRef
go back to reference Dean C (1987) Psychiatric morbidity following mastectomy: preoperative predictors and types of illness. J Psychosom Res 31:385–392PubMedCrossRef Dean C (1987) Psychiatric morbidity following mastectomy: preoperative predictors and types of illness. J Psychosom Res 31:385–392PubMedCrossRef
go back to reference Den Oudsten BL, Van Heck GL, Van der Steeg AFW, Roukema JA, De Vries J (2009) Predictors of depressive symptoms 12 months after surgical treatment of early-stage breast cancer. Psycho-oncology 18:1230–1237. doi:10.1002/pon.1518 CrossRef Den Oudsten BL, Van Heck GL, Van der Steeg AFW, Roukema JA, De Vries J (2009) Predictors of depressive symptoms 12 months after surgical treatment of early-stage breast cancer. Psycho-oncology 18:1230–1237. doi:10.​1002/​pon.​1518 CrossRef
go back to reference Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM, Henrichs M, Carnicke CL (1983) The prevalence of psychiatric disorders among cancer patients. JAMA 249:751–757PubMedCrossRef Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM, Henrichs M, Carnicke CL (1983) The prevalence of psychiatric disorders among cancer patients. JAMA 249:751–757PubMedCrossRef
go back to reference Fallowfield LJ, Hall A, Maguire GP, Baum M (1990) Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial. BMJ 301:575–580PubMedPubMedCentralCrossRef Fallowfield LJ, Hall A, Maguire GP, Baum M (1990) Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial. BMJ 301:575–580PubMedPubMedCentralCrossRef
go back to reference Fulton CL (1997) The physical and psychological symptoms experienced by patients with metastatic breast cancer before death. Eur J Cancer Care 6:262–266CrossRef Fulton CL (1997) The physical and psychological symptoms experienced by patients with metastatic breast cancer before death. Eur J Cancer Care 6:262–266CrossRef
go back to reference Golden-Kreutz DM, Andersen BL (2004) Depressive symptoms after breast cancer surgery: relationships with global, cancer-related, and life event stress. Psycho-oncol 13:211–220. doi:10.1002/pon.736 CrossRef Golden-Kreutz DM, Andersen BL (2004) Depressive symptoms after breast cancer surgery: relationships with global, cancer-related, and life event stress. Psycho-oncol 13:211–220. doi:10.​1002/​pon.​736 CrossRef
go back to reference Grabsch B, Clarke DM, Love A, McKenzie DP, Snyder RD, Bloch S, Smith G, Kissane DW (2006) Psychological morbidity and quality of life in women with advanced breast cancer: a cross-sectional survey. Palliat Support Care 4:47–56PubMedCrossRef Grabsch B, Clarke DM, Love A, McKenzie DP, Snyder RD, Bloch S, Smith G, Kissane DW (2006) Psychological morbidity and quality of life in women with advanced breast cancer: a cross-sectional survey. Palliat Support Care 4:47–56PubMedCrossRef
go back to reference Hegel MT, Moore CP, Collins ED, Kearing S, Gillock KL, Riggs RL, Clay KF, Ahles TA (2006) Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer. Cancer 107:2924–2931. doi:10.1002/cncr.22335 PubMedCrossRef Hegel MT, Moore CP, Collins ED, Kearing S, Gillock KL, Riggs RL, Clay KF, Ahles TA (2006) Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer. Cancer 107:2924–2931. doi:10.​1002/​cncr.​22335 PubMedCrossRef
go back to reference Hopwood P, Howell A, Maguire P (1991) Psychiatric morbidity in patients with advanced cancer of the breast: prevalence measured by two self-rating questionnaires. Br J Cancer 64:349–352PubMedPubMedCentralCrossRef Hopwood P, Howell A, Maguire P (1991) Psychiatric morbidity in patients with advanced cancer of the breast: prevalence measured by two self-rating questionnaires. Br J Cancer 64:349–352PubMedPubMedCentralCrossRef
go back to reference Maguire GP, Lee EG, Bevington DJ, Küchemann CS, Crabtree RJ, Cornell CE (1978) Psychiatric problems in the first year after mastectomy. Br Med J 1:963–965PubMedPubMedCentralCrossRef Maguire GP, Lee EG, Bevington DJ, Küchemann CS, Crabtree RJ, Cornell CE (1978) Psychiatric problems in the first year after mastectomy. Br Med J 1:963–965PubMedPubMedCentralCrossRef
go back to reference McKenna MC, Zevon MA, Corn B, Rounds J (1999) Psychosocial factors and the development of breast cancer: a meta-analysis. Health Psychol 18:520–531PubMedCrossRef McKenna MC, Zevon MA, Corn B, Rounds J (1999) Psychosocial factors and the development of breast cancer: a meta-analysis. Health Psychol 18:520–531PubMedCrossRef
go back to reference Okamura M, Yamawaki S, Akechi T, Taniguchi K, Uchitomi Y (2005) Psychiatric disorders following first breast cancer recurrence: prevalence, associated factors and relationship to quality of life. Jpn J Clin Oncol 35:302–309. doi:10.1093/jjco/hyi097 PubMedCrossRef Okamura M, Yamawaki S, Akechi T, Taniguchi K, Uchitomi Y (2005) Psychiatric disorders following first breast cancer recurrence: prevalence, associated factors and relationship to quality of life. Jpn J Clin Oncol 35:302–309. doi:10.​1093/​jjco/​hyi097 PubMedCrossRef
go back to reference Ollonen P, Lehtonen J, Eskelinen M (2005) Stressful and adverse life experiences in patients with breast symptoms; a prospective case-control study in Kuopio Finland. Anticancer Res 25:531–536PubMed Ollonen P, Lehtonen J, Eskelinen M (2005) Stressful and adverse life experiences in patients with breast symptoms; a prospective case-control study in Kuopio Finland. Anticancer Res 25:531–536PubMed
go back to reference Somerset W, Stout SC, Miller AH, Musselman D (2004) Breast cancer and depression. Oncol (Williston Park NY) 18:1021–1034 (discussion 1035–1036, 1047–1048) Somerset W, Stout SC, Miller AH, Musselman D (2004) Breast cancer and depression. Oncol (Williston Park NY) 18:1021–1034 (discussion 1035–1036, 1047–1048)
go back to reference Spiegel D (1996) Cancer and depression. Psychiatry, Suppl Spiegel D (1996) Cancer and depression. Psychiatry, Suppl
go back to reference Spiegel D (1997) Psychosocial aspects of breast cancer treatment. Semin Oncol 24:S1–36–S1–47 Spiegel D (1997) Psychosocial aspects of breast cancer treatment. Semin Oncol 24:S1–36–S1–47
Metadata
Title
Prevalence of depression, anxiety and their risk factors in German women with breast cancer in general and gynecological practices
Authors
Louis Jacob
Laura Bleicher
Karel Kostev
Matthias Kalder
Publication date
01-02-2016
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 2/2016
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-015-2048-5

Other articles of this Issue 2/2016

Journal of Cancer Research and Clinical Oncology 2/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.